In the journal npj Breast Cancer, researchers reported they identified a particular gene expression pattern in normal-appearing breast tissue around tumors that was linked to lower 10-year survival rates for women with estrogen receptor-positive breast cancer.
Blossom Damania, PhD, has been named the vice dean for research at the UNC School of Medicine. She will assume the new role effective July 1. Terry Magnuson, PhD, who has held the position since 2010, has been named the vice chancellor for research at UNC-Chapel Hill. Damania, the Cary C. Boshamer Distinguished Professor of Microbiology and Immunology, has served as assistant dean for research since 2014.
The drug sorafenib can have serious side effects and significant out-of-pocket costs for advanced liver cancer patients, according to a study led by UNC’s Hanna Sanoff, MD, MPH.
Cancer patients with the EZH2 gene mutation could benefit from a new therapy UNC School of Medicine and UNC Lineberger researchers have now tested successfully in lab models.
UNC Lineberger member Satish Gopal, MD, MPH, has called for a commitment to contribute resources and energy to control cancer in less-resourced countries where there are significant gaps in cancer awareness, prevention, diagnosis, and treatment.
A study led by UNC Lineberger researchers has found that for women who have had a false-positive mammogram result, their likelihood to get screened at recommended intervals depends on the timing of their last screen. Louise Henderson, PhD, will present the findings at the American Association for Cancer Research Annual Meeting in New Orleans, Monday, April 18.
UNC School of Medicine professor and basic scientist Keith Burridge has conducted seminal research on the basic building blocks of cells for four decades.
By using lasers, UNC School of Medicine scientists can switch off and on proteins to watch how cells react quickly to their new reality.
Sancar, the 2015 winner of the Nobel Prize in Chemistry, donated his prize money to a Chapel Hill foundation. Smithies donated his monetary award to four universities, including UNC.
Study raises concerns about access to proven, yet expensive, drug therapy for HER2 subtype
A research team including Helen Lazear, PhD, assistant professor of microbiology and immunology, has established a mouse model for testing of vaccines and therapeutics to battle Zika virus.
UNC / NC State researchers devise a new nanotechnology to enhance the body’s own immune response to kill skin cancer tumors.
Study uncovers genetic differences for kidney cancer that may contribute to survival disparity in African-Americans
A UNC Lineberger-led study has identified genetic differences in tumors of African-Americans with the most common type of kidney cancer compared with whites. The researchers say the findings could help explain lower survival rates for African-Americans with clear cell renal cell carcinoma.
UNC Hospitals’ care earns Blue Distinction® Center+ Designation for Quality and Cost-Efficiency for Five Service Lines
Blue Cross and Blue Shield of North Carolina ranked UNC Hospitals’ bariatric surgery, cardiac care, knee & hip replacement, spine surgery, maternity and complex & rare cancer service lines highly as part of the Blue Distinction Specialty Care program
In a first-of-its-kind-study, researchers at the University of North Carolina Lineberger Comprehensive Cancer Center discovered and applied a new screening technique capable of testing thousands of potential drug compounds to see if those compounds can reverse abnormal DNA unwinding in Ewing sarcoma, a bone and soft tissue cancer that’s most common in teens and young adults.
The joint UNC/NC State researcher also earned a grant from JDRF and Sanofi to further develop glucose responsive insulin therapies for diabetes.
As part of the “Cancer Moonshot” federal initiative to spur breakthroughs in cancer research, Biden hosted a roundtable discussion on Feb. 10 at the Duke University School of Medicine that featured cancer experts and leaders from UNC. Among the experts chosen for the panel were Stephanie Wheeler, PhD, UNC Lineberger member and assistant professor of health policy and management at the UNC Gillings School of Global Public Health, and Niklaus Steiner, UNC professor and co-founder of the Chapel Hill-based Be Loud! Sophie Foundation, which supports adolescents and young adults with cancer.
A UNC Lineberger researcher was first-author of a report published in the Journal of Clinical Oncology that details guidelines for the active surveillance of men with low-risk prostate cancer. The guidelines, originally authored by Cancer Care Ontario, were reviewed and endorsed by the American Society of Clinical Oncology with some revisions.
UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention
Joint statement urges parents, young adults and physicians to act to increase vaccination rates
In a study published in the journal Annals of Surgery, researchers report that breast cancer patients surveyed about their knowledge of breast reconstruction were only moderately informed about the procedure, and their knowledge of complications was low.